Large, Wide‐Neck, Side‐Wall Aneurysm Treatment in Canines Using NeuroCURE: A Novel Liquid Embolic
Open Access
- 1 September 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 3 (5)
Abstract
Background: Untreated intracranial aneurysms can rupture and result in high rates of morbidity and mortality. Although there are numerous approved endovascular aneurysm treatment devices, most require dual anti‐platelet therapy, are minimally biocompatible, or are prone to recanalization. Neurovascular Controlled Uniform Rapid Embolic (NeuroCURE) is an innovative polymer gel material with long‐term stability, biocompatibility, and hemocompatibility developed for the treatment of large, wide‐neck aneurysms. Methods: Sidewall aneurysms were surgically created in 10 canines and NeuroCURE was injected through a 0.025 microcatheter under a single balloon inflation period. Aneurysm treatment was angiographically assessed post‐embolization and pre‐term with Raymond–Roy occlusion classification and a qualitative flow grade scale. Aneurysm neck stability and biocompatibility was histologically assessed to grade platelet/fibrin thrombus, percent endothelialization, and neointimal formation. Aneurysm sac stability was assessed by NeuroCURE sac content, inflammation, and neo‐angiogenesis scales. Results: Explanted aneurysms exhibited a smooth surface at the aneurysm neck with nearly complete neointimal coverage at 3‐months. By 6‐months, neck endothelialization was 100% in all animals (average Raymond–Roy occlusion classification of 1.2), with no instances of aneurysm recanalization or parent vessel flow compromise. Biocompatibility assessments verified a lack of inflammatory response, neo‐angiogenesis, and platelet/fibrin thrombus formation. Conclusion: The NeuroCURE material promotes progressive occlusion of wide‐necked side wall aneurysms over time without the need for dual antiplatelet agents. NeuroCURE also promotes neointimal tissue infill without dependence on thrombus formation and thus resists aneurysm recanalization. NeuroCURE remains a compelling investigational device for the treatment of intracranial aneurysms.Keywords
This publication has 42 references indexed in Scilit:
- In vivo embolization of lateral wall aneurysms in canines using the liquid-to-solid gelling PPODA-QT polymer system: 6-month pilot studyJournal of Neurosurgery, 2013
- Endovascular Treatment of Wide-Necked Intracranial Aneurysms Using Balloon-Assisted Technique with HyperForm BalloonJournal of Korean Neurosurgical Society, 2010
- EVALUATION OF ONYX HD-500 EMBOLIC SYSTEM IN THE TREATMENT OF 84 WIDE-NECK INTRACRANIAL ANEURYSMSNeurosurgery, 2009
- Coiling of Very Large and Giant Basilar Tip Aneurysms: Midterm Clinical and Angiographic ResultsAmerican Journal of Neuroradiology, 2007
- Long-Term Angiographic Recurrences After Selective Endovascular Treatment of Aneurysms With Detachable CoilsStroke, 2003
- Guglielmi Detachable Coil embolization of cerebral aneurysms: 11 years' experienceJournal of Neurosurgery, 2003
- Natural history of the neck remnant of a cerebral aneurysm treated with the Guglielmi detachable coil systemJournal of Neurosurgery, 2000
- Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular embolization is considered the first optionJournal of Neurosurgery, 2000
- Nonadhesive Liquid Embolic Agent for Cerebral Arteriovenous Malformations: Preliminary Histopathological Studies in Swine Rete MirabileNeurosurgery, 1998
- Embolic materials for endovascular treatment of cerebral lesionsJournal of Biomaterials Science, Polymer Edition, 1997